Positive list system re-emerging as contentious issue

The government is firm in pushing for drug pricing reform, which it says cannot be the subject of transparency as it is part of the country's healthcare policies that ensure the financial stability of the national health insurance scheme by cutting down the prices of insurance-covered medicines.

However, some healthcare experts and industrial watchers question the process of evaluating the c...